Gordon Hamilton MD, CEO, participated in the RNA Leaders Europe Congress in Basel, 15 – 16 March, presenting a poster entitled ‘MAGNA™: single molecule real-time analysis of dynamic nucleic acid interactions’. We discuss how our state-of-the-art technology platform, MAGNA™ can be used to study complex biomolecular interactions between nucleic acids and small molecules, a topic that is gathering significant excitement in the pharmaceutical industry.

MAGNA™ can be used to study complex biomolecular interactions between nucleic acids and small molecules, a topic that is gathering significant excitement in the pharmaceutical industry.

View Poster

Dr Steve Allen (Chief Business Officer) and Dr Jimmy Ouellet (Chief Scientist) of Depixus participated in the Hanson Wade Assay Development & Screening Summit from 23 to 24 August, 2023, Boston, USA.

The inaugural RNA Assay Development & Screening Summit is the only industry-focused RNA assay discovery networking and discussion forum, dedicated to addressing and overcoming challenges drug developers face when developing RNA assays and screening tools, for efficient drug discovery.

Dr Jimmy Ouellet, Chief Scientist, talked about how Depixus is addressing the biggest bottleneck in the screening of lead compounds using its powerful new MAGNA™ technology.

View Poster